rheumatology
Tag details
Welcome to the 'rheumatology' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'rheumatology'.
Look up
"rheumatology"
at The Free Dictionary
Latest blogosphere posts tagged “rheumatology”
-
Top 10 for 09: No. 9
Pathophilia —
Authority: 127
No. 9: Belimumab Buzz There were few notable FDA approvals for "new molecular entities" (NMEs) in 2009: Urolic (febuxostat; Takeda) is the first new treatment for gout in more than 40 years. (But come on: its gout.) Simponi (galimumab;...6 days ago -
Contemporary Targeted Therapies in Rheumatology
JOURNAL KEPERAWATAN, MAKALAH KESEHATAN, ASKEP KEPERAWATAN —
Authority: 103
Publisher: Informa Healthcare Number Of Pages: 636 Publication Date: 2007-10-24 ISBN-10 / ASIN: 1841844845 ISBN-13 / EAN: 9781841844848 Binding: Hardcover Product Description: Targeted Therapies in Rheumatology established itself as an excellent reference for all those needing to know about the clinical implications ...1 week ago -
Contemporary Targeted Therapies in Rheumatology
JOURNAL KEPERAWATAN, MAKALAH KESEHATAN, ASKEP KEPERAWATAN —
Authority: 103
Publisher: Informa Healthcare Number Of Pages: 636 Publication Date: 2007-10-24 ISBN-10 / ASIN: 1841844845 ISBN-13 / EAN: 9781841844848 Binding: Hardcover Product Description: Targeted Therapies in Rheumatology established itself as an excellent reference for all those needing to know about the clinical implications ...1 week ago -
ChemoCentryx Initiates Phase 2 Clinical Trial Of CCX354 For The Treatment Of Rheumatoid Arthritis
Health News from Medical News Today —
Authority: 713
ChemoCentryx, Inc. announced that it has begun enrolling patients in a Phase 2 clinical trial of CCX354, an orally-bioavailable, novel, small molecule drug designed to specifically target the CCR1 chemokine receptor for the treatment of rheumatoid arthritis (RA). CCX354 is a highly potent and selective antagonist of ...1 week ago -
Clue to Arthritis Spread [The World in Medicine]
JAMA —
Authority: 443
2 weeks ago -
Rheumatoid Arthritis Patients Want Pain-Free Shopping Days At Christmas
Health News from Medical News Today —
Authority: 713
A survey of women in the United Kingdom (U.K.) reveals that rheumatoid arthritis (RA) has a severe emotional and physical impact on people living with the disease and their families. Feelings of detachment and isolation from those closest to them due to RA are especially prevalent at Christmas, which ...2 weeks ago -
Doha: Rheumatologist
International Jobs for Physicians, Nurses and Allied Health —
Authority: 122
Our client is a modern 250 bed state of the art hospital in Doha Qatar. The hospital has a vacancy for aConsultant RheumatologyWhen required – Immediate or latest by January 2010 Qualification – American Board in Internal Medicine, or Royal College Degree before 1996 or after 1996 with CCST, or German Facharzt ...2 weeks ago -
Genentech And Biogen Idec Announce Positive Results From First Phase III Trial Of Ocrelizumab In Rheumatoid Arthritis
Health News from Medical News Today —
Authority: 713
Genentech, Inc. a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec (Nasdaq: BIIB) announced today a Phase III study (STAGE) of the investigational humanized anti-CD20 monoclonal antibody ocrelizumab given in combination with methotrexate (MTX) met its primary endpoint of improving ...2 weeks ago -
Search Job Portal
International Jobs for Physicians, Nurses and Allied Health - atlasmed.com —
Authority: 153
Welcome to AMI Health Services, one of the leading retained and contingency search firms to the healthcare industry. We recruit for Jobs for Physicians, Nurses and Allied Health for Hospitals in North America and International. Our portfolio includes Executive Management and Finance Professionals as well as Operation ...2 weeks ago -
Roche, Genentech And Biogen Idec Announce Positive Results From First Phase III Trial Of Ocrelizumab In Rheumatoid Arthritis
Health News from Medical News Today —
Authority: 713
Roche (SIX: RO, ROG; OTCQX: RHHBY), Genentech, Inc. a wholly owned member of the Roche Group, and Biogen Idec (Nasdaq: BIIB) announced a Phase III study (STAGE) of the investigational humanized anti-CD20 monoclonal antibody ocrelizumab given in combination with methotrexate (MTX) met its primary endpoint of improving ...2 weeks ago -
Colcrys – refined tough
AdPharm Blog —
Authority: 148
Tough as ever, but a bit more refined Click here to see the details and full-size version in the gallery This ad and thousands more can be seen on the AdPharm gallery , the largest online pharmaceutical advertising gallery.2 weeks ago -
Neovacs Initiates A Phase II Clinical Trial Of TNF-alpha Kinoid In Rheumatoid Arthritis Patients Failing TNF-alpha Monoclonal Antibody Therapy
Health News from Medical News Today —
Authority: 713
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test ...2 weeks ago -
Biogen Idecs Oral Compound BG-12 Achieves Development Milestones In MS And RA
Health News from Medical News Today —
Authority: 713
Biogen Idec (NASDAQ: BIIB) today announced that its oral compound BG-12 (dimethyl fumarate) achieved key milestones in clinical trials for multiple sclerosis (MS) and rheumatoid arthritis (RA). In recent months, the last patient was enrolled in the CONFIRM trial, the second of two Phase III trials designed to evaluate ...3 weeks ago -
Too Much Physical Activity May Lead To Arthritis
Health News from Medical News Today —
Authority: 713
Middle-aged men and women who engage in high levels of physical activity may be unknowingly causing damage to their knees and increasing their risk for osteoarthritis, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). "Our data suggest that people with ...3 weeks ago -
Is There A Blood Test For Rheumatoid Arthritis?
Healthy Living Times —
Authority: 130
Rheumatoid arthritis (RA) is the most common inflammatory form of arthritis. It affects roughly 2 million Americans. It is a chronic, systemic, autoimmune disorder for which there is no known cure. However, there are very effective medicine regimens that can control the disease and get it into remission. The major ...4 weeks ago -
Chicken Capsules Good For Aching Joints
Health News from Medical News Today —
Authority: 713
Chicken collagen can provide relief from rheumatoid arthritis (RA) symptoms. A randomised, controlled trial, published in BioMed Centrals open access journal Arthritis Research & Therapy, has found that Chicken type II collagen (CCII), a protein extracted from the cartilage of chicken breast, is a safe and ...4 weeks ago -
Stroke and heart disease trigger identified
Thaindian News —
Authority: 740
Washington, Dec 1 (ANI): Scientists from Imperial College London have identified a molecule that triggers damage in arteries, which causes heart attacks and strokes.They hope that the condition could potentially be treated by blocking the molecule that triggers the damage.The trigger identified in the research is a ...4 weeks ago -
ArGentis Acquires Rights To Rheumatoid Arthritis Therapy Entering Phase I Clinical Trial
Health News from Medical News Today —
Authority: 713
arGentis Pharmaceuticals, LLC announced that it will collaborate with the University of Tennessee Health Science Center (UTHSC) and the Veterans Affairs Medical Center of Memphis (VAMC) to initiate the first human clinical evaluation of an oral altered peptide ligand (APL), ARG301, in a Phase I study of Rheumatoid ...4 weeks ago -
Higher Risk Of Knee Arthritis Linked To Too Much Exercise
Health News from Medical News Today —
Authority: 713
A new study by radiologists found that middle-aged men and women who do lots of exercise, and particularly high impact activities like running and jumping, may be unknowingly causing damage to their knees and putting themselves at greater risk of developing osteoarthritis.4 weeks ago -
Given A Choice, Arthritis Patients Take More Conservative Clinical Approach
Health News from Medical News Today —
Authority: 713
A recent study suggests that increasing patient responsibility for making medical decisions may decrease their willingness to accept risky treatment options. Details of this proof-of-concept study appear in the December issue of Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the ...4 weeks ago

